$Dogecoin(DOGE.CC)$ .35???

$Cassava Sciences(SAVA.US)$ This is exactly Why the warrants are also needed to show the true share float of total amount of shares and the ones that are being shorted with synthetic shares and dark pool. Look at the Algo manipulation of : 1 1 1 1 and 3 3.
Shorts thinking they can do this forever. They got away with doing this daily for 3 years but this has to stop now especially with cybersecurity now onboard member and warrants.

$Cassava Sciences(SAVA.US)$ Fake, naked shares selling and shorts forgetting FBI Cybersecurity on Board that will expose them.

$Cassava Sciences(SAVA.US)$ Alzheimer's is a debilitating disease that is fatal. SAVA is a breakthrough safe treatment that shows improvement on mild patients.With all those patients in the previous trials that wanted to continue to PHASE 3 trials, that should have already let the world and market know that it is safe and it works. There is no other way around that to all those shorts who tried to stop that for their greed.The New High Recruits on the SAVANGERS Board with Bio Approvals Resume an...

$Cassava Sciences(SAVA.US)$
a bit of usual market manipulation going on.

$Cassava Sciences(SAVA.US)$ Insiders continue to buy again and no sales. They continue to show confidence in SAVA while it is now in Phase 3 and almost fully enrolled with many patients already completed phase 3. A well-tolerated treatment that gives benefits and hope for mild Alzheimer's patients. Help is on the way for those all over the world  with debilitating disease.

$Cassava Sciences(SAVA.US)$ The shorts & FUD people who try so hard to dissuade the public from SAVA, SAVA has been in agreement with the U.S. Food and Drug Administration (FDA) under a Special Protocol Assessment (SPA) for both of its pivotal Phase 3 studies of oral simufilam for the treatment of patients with Alzheimer’s disease. "These SPA agreements document that FDA has reviewed and agreed upon the key design features of Cassava Sciences’ Phase 3 study protocols of simufilam for the treatme...

$Cassava Sciences(SAVA.US)$ Market Manipulators are playing with stock price to keep it under $25 this week. Meanwhile, The potential of what SAVA is doing to treat Alzheimers is Breakthrough and Sanford Robertson is the Director of Cassava Sciences Inc and owns about 1,024,765 shares of Cassava Sciences Inc (SAVA) stock worth over $26 Million. Insiders never sold!!!

$Cassava Sciences(SAVA.US)$ More news outlet picking up on SAVA breakthrough ! #ENDALZ !
Simufilam, an investigational oral drug for Alzheimer's Disease, improved cognition in 47% of treated patients in a Phase 2 study